Biosimilars in Primary Care: A Brief CME Module on Addressing Patient Concerns
Your patient asks, "Will switching to a biosimilar make my disease worse?" Learn how to confidently address their concerns.
Read the full articleYou might also wanna read
FDA Moves to Speed Biosimilar Development, Lower Prescription Drug Costs
The FDA has unveiled draft guidance to accelerate biosimilar approvals, reduce testing costs, and expand access to affordable biologic alter
CME | DPC, VBC & Me: Finding Your Fit Within Family Medicine Payment Models
In this episode of CME on the Go, our hosts engage in an in-depth discussion on two essential practice models for family physicians: Direct
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this re-released episode of CME on the Go, originally published on 12/1/2025, our hosts discuss the complexities of diagnosing and treati
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this episode of CME on the Go, our hosts discuss the complexities of diagnosing and treating headaches in primary care. They cover common
Biosimilar for Denosumab
Over the past two years, Canada has undergone a significant and coordinated transition in osteoporosis care: the shift to biosimilar denosum
CME | Private Practice, Public Impact: Finding Your Fit in Modern Medicine
In this episode of CME On the Go, Jason Marker , MD, MPA, FAAFP and Lauren Brown-Berchtold , MD, FAAFP, discuss how private practice in fami
Comments
Sign in to join the conversation.
No comments yet. Be the first.